selected publications
-
A machine learning and network framework to discover new indications for small molecules.
PLoS computational biology.
2020
Academic Article
GET IT
Times cited: 8 -
Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson's Disease.
CNS drugs.
2020
Review
GET IT
Times cited: 5 -
Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials.
JAMA neurology.
2020
Academic Article
GET IT
Times cited: 5 -
Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease.
2020
GET IT
Times cited: 213 -
The future of stem cell therapies for Parkinson disease.
Nature reviews. Neuroscience.
2020
Review
GET IT
Times cited: 144 -
Neurophysiological Biomarkers of Parkinson's Disease.
Journal of Parkinson's disease.
2020
Academic Article
GET IT
Times cited: 18 -
Sex and Gender Driven Modifiers of Alzheimer's: The Role for Estrogenic Control Across Age, Race, Medical, and Lifestyle Risks.
Frontiers in aging neuroscience.
2019
Review
GET IT
Times cited: 109 -
Motor phenotype classification in moderate to advanced PD in BioFIND study.
Parkinsonism & related disorders.
2019
Academic Article
GET IT
Times cited: 15 -
Data-Driven Subtyping of Parkinson's Disease Using Longitudinal Clinical Records: A Cohort Study.
Scientific reports.
2019
Academic Article
GET IT
Times cited: 72 -
18F-FPEB PET/CT Shows mGluR5 Upregulation in Parkinson's Disease.
Journal of neuroimaging : official journal of the American Society of Neuroimaging.
2018
Academic Article
GET IT
Times cited: 21 -
Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology.
2018
Review
GET IT
Times cited: 51 -
Noninvasive PK11195-PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson's Disease.
Journal of neuroimaging : official journal of the American Society of Neuroimaging.
2018
Academic Article
GET IT
Times cited: 22 -
Valbenazine as the first and only approved treatment for adults with tardive dyskinesia.
Expert review of clinical pharmacology.
2018
Review
GET IT
Times cited: 8 -
Repairing the Brain: Cell Replacement Using Stem Cell-Based Technologies.
Journal of Parkinson's disease.
2018
Review
GET IT
Times cited: 13 -
Kufor-Rakeb Syndrome Due to a Novel ATP13A2 Mutation in 2 Chinese-American Brothers.
2017
GET IT
Times cited: 1 -
Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.
Movement disorders : official journal of the Movement Disorder Society.
2017
Academic Article
GET IT
Times cited: 98 - Evidence for the use of pimavanserin in the treatment of Parkinson's disease psychosis. Therapeutic advances in neurological disorders. 2016 Review GET IT
-
The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort.
Movement disorders : official journal of the Movement Disorder Society.
2016
Academic Article
GET IT
Times cited: 38 -
Future needs for informed consent in stem cell clinical trials in neurodegenerative diseases.
Neural regeneration research.
2016
Academic Article
GET IT
Times cited: 4 -
First-in-human cell transplant trials in Parkinson's disease: The need for an improved informed consent process.
Parkinsonism & related disorders.
2015
Academic Article
GET IT
Times cited: 16 -
Dance for PD: a preliminary investigation of effects on motor function and quality of life among persons with Parkinson's disease (PD).
Journal of neural transmission (Vienna, Austria : 1996).
2015
Academic Article
GET IT
Times cited: 61 -
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
JAMA neurology.
2014
Academic Article
GET IT
Times cited: 270 -
Sex differences in cerebral energy metabolism in Parkinson's disease: a phosphorus magnetic resonance spectroscopic imaging study.
Parkinsonism & related disorders.
2014
Academic Article
GET IT
Times cited: 20 -
Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease.
Journal of neuroimaging : official journal of the American Society of Neuroimaging.
2013
Academic Article
GET IT
Times cited: 35 -
Neuroimaging markers of motor and nonmotor features of Parkinson's disease: an 18f fluorodeoxyglucose positron emission computed tomography study.
Dementia and geriatric cognitive disorders.
2013
Academic Article
GET IT
Times cited: 77 -
Biomarkers in Parkinson's disease: an update.
Current opinion in neurology.
2012
Review
GET IT
Times cited: 55 -
Clinical characteristics of exacerbations in Parkinson disease.
The neurologist.
2012
Academic Article
GET IT
Times cited: 40 -
Biomarkers of Parkinson's disease and Dementia with Lewy bodies.
Progress in neurobiology.
2011
Review
GET IT
Times cited: 27 -
The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.
Brain : a journal of neurology.
2011
Review
GET IT
Times cited: 153 -
Disease modification in Parkinson's disease.
Drugs & aging.
2011
Review
GET IT
Times cited: 35 -
Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography.
Clinical ophthalmology (Auckland, N.Z.).
2010
Academic Article
GET IT
Times cited: 103 -
Clinical predictors of frequent patient telephone calls in Parkinson's disease.
Parkinsonism & related disorders.
2010
Academic Article
GET IT
Times cited: 17 -
How are we doing with the treatment of essential tremor (ET)?: Persistence of patients with ET on medication: data from 528 patients in three settings.
European journal of neurology.
2010
Academic Article
GET IT
Times cited: 71 - Coenzyme Q10 effects in neurodegenerative disease. Neuropsychiatric disease and treatment. 2009 Academic Article GET IT
-
Mirror movements in patients with essential tremor.
Movement disorders : official journal of the Movement Disorder Society.
2009
Academic Article
GET IT
Times cited: 16 -
Metabolomic profiling in LRRK2-related Parkinson's disease.
PloS one.
2009
Academic Article
GET IT
Times cited: 127 -
Older onset essential tremor: More rapid progression and more degenerative pathology.
Movement disorders : official journal of the Movement Disorder Society.
2009
Academic Article
GET IT
Times cited: 64 -
Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease.
Annals of the New York Academy of Sciences.
2008
Review
GET IT
Times cited: 54 -
Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.
Nature clinical practice. Neurology.
2008
Review
GET IT
Times cited: 600 -
Cancer and blood concentrations of the comutagen harmane in essential tremor.
Movement disorders : official journal of the Movement Disorder Society.
2008
Academic Article
GET IT
Times cited: 9 - Rasagiline in treatment of Parkinson's disease. Neuropsychiatric disease and treatment. 2008 Academic Article GET IT
- Case study of an unusual variant of restless leg syndrome. Movement disorders : official journal of the Movement Disorder Society. 2008 Letter GET IT
-
Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor.
Neurotoxicology.
2007
Academic Article
GET IT
Times cited: 73 -
Young-onset Parkinson's disease: hospital utilization and medical comorbidity in a nationwide survey.
Neuroepidemiology.
2007
Academic Article
GET IT
Times cited: 11 - Retraction. Young-onset Parkinson's disease: hospital utilization and medical comorbidity in a nationwide survey. Movement disorders : official journal of the Movement Disorder Society. 2007 Academic Article GET IT
-
Excitotoxicity.
Handbook of clinical neurology.
2007
Academic Article
GET IT
Times cited: 2 -
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease.
Proceedings of the National Academy of Sciences of the United States of America.
2006
Academic Article
GET IT
Times cited: 139 -
Late-life depression: a neuropsychiatric approach.
Expert review of neurotherapeutics.
2006
Review
GET IT
Times cited: 20 -
Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
Expert review of neurotherapeutics.
2005
Review
GET IT
Times cited: 38 -
Intravascular lymphoma: magnetic resonance imaging correlates of disease dynamics within the central nervous system.
Journal of neurology, neurosurgery, and psychiatry.
2005
Academic Article
GET IT
Times cited: 74 -
Entacapone in the management of Parkinson's disease.
Expert opinion on pharmacotherapy.
2002
Review
GET IT
Times cited: 8 -
Expression of c-fos, c-jun, and c-jun N-terminal kinase (JNK) in a developmental model of induced apoptotic death in neurons of the substantia nigra.
Journal of neurochemistry.
1999
Academic Article
GET IT
Times cited: 77 -
Increased expression of cyclin-dependent kinase 5 in induced apoptotic neuron death in rat substantia nigra.
Neuroscience letters.
1997
Academic Article
GET IT
Times cited: 47 -
Neuron death in the substantia nigra of weaver mouse occurs late in development and is not apoptotic.
The Journal of neuroscience : the official journal of the Society for Neuroscience.
1996
Academic Article
GET IT
Times cited: 51 -
Apoptosis in substantia nigra following developmental hypoxic-ischemic injury.
Neuroscience.
1995
Academic Article
GET IT
Times cited: 66 -
Genetic analysis of laminin A reveals diverse functions during morphogenesis in Drosophila.
Development (Cambridge, England).
1993
Academic Article
GET IT
Times cited: 85 -
Cell type specific trans-acting factors are involved in alternative splicing of human fibronectin pre-mRNA.
The EMBO journal.
1989
Academic Article
GET IT
Times cited: 30 -
Sequence analysis and in vivo expression show that alternative splicing of ED-B and ED-A regions of the human fibronectin gene are independent events.
Nucleic acids research.
1988
Academic Article
GET IT
Times cited: 23